Login Company Therapies Products Fresenius Kabi classroom Diary Contact WELCOME Fresenius Kabi is a global healthcare company specializing in vital medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services serve the care of critical and chronic patients. We are committed to providing healthcare professionals with essential medicines and technologies and finding the best answers to the challenges they face. NEWS 04/25/2017 Fresenius Kabi acquires the Biosimilars business of Merck and Akorn (USA) 01/19/2017 Fresenius Kabi receives the CE Marking for the CONOX anesthetic depth monitor. 02/24/2016 Fresenius: Excellent financial results for 2015 - 25% dividend increase - Good prospects for 2016 - New medium-term growth targets 01/08/2016 Fresenius Kabi acquires ready-to-use medicines and a pharmaceutical plant from Becton Dickinson (USA) 11/15/2015 The German pharmaceutical company Fresenius Kabi invests 20 million euros to almost double the production capacity of the Vilassar de Dalt plant Fresenius Kabi España, SAU a Fresenius Kabi Group company © 2017 Start Web map Legal note Cookies policy Cond. sale Our site requires cookies to function, click here for more information